Author Index

Search or browse for an author across our entire electronic archive

Search results for: T
Results 1 - 10 of 1192 shown below

  • Tárkányi, G

    F Orosz, B Comin, B Raïs, J Puigjaner, J Kovács, G Tárkányi, T ács, T Keve, M Cascante and J Ovádi

    New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies

    doi:10.1038/sj.bjc.6690218

  • Téhard, B

    F Canzian, J D McKay, R J Cleveland, L Dossus, C Biessy, S Rinaldi, S Landi, C Boillot, S Monnier, V Chajès, F Clavel-Chapelon, B Téhard, J Chang-Claude, J Linseisen, P H Lahmann, T Pischon, D Trichopoulos, A Trichopoulou, D Zilis, D Palli, R Tumino, P Vineis, F Berrino, H B Bueno-de-Mesquita, C H van Gils, P H M Peeters, G Pera, E Ardanaz, M-D Chirlaque, J R Quirós, N Larrañaga, C Martínez-García, N E Allen, T J Key, S A Bingham, K-T Khaw, N Slimani, T Norat, E Riboli and R Kaaks

    Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study

    advance online publication, 2006-01-10 00:00:00.000;

    doi:10.1038/sj.bjc.6602936

  • Tórtola, S

    M Palicio, I Blanco, S Tórtola, I González, E Marcuello, J Brunet, F Lluis, J J González-Aguilera, M A Peinado and G Capella

    Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer

    doi:10.1054/bjoc.1999.0959

  • Tørring, N

    N Tørring, M Borre, K D Sørensen, C L Andersen, C Wiuf and T F Ørntoft

    Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

    advance online publication, 2007-01-23 00:00:00.000;

    doi:10.1038/sj.bjc.6603476

  • Törmänen, U

    U Törmänen, K Nuorva, Y Soini and P Pääkkö

    Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium

    doi:10.1038/sj.bjc.6690159

  • Törnberg, S

    A-B Wiréhn, S Törnberg and J Carstensen

    Serum cholesterol and testicular cancer incidence in 45 000 men followed for 25 years

    advance online publication, 2005-04-12 00:00:00.000;

    doi:10.1038/sj.bjc.6602539

  • P Naucler, W Ryd, S Törnberg, A Strand, G Wadell, B G Hansson, E Rylander and J Dillner

    HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study

    advance online publication, 2007-06-05 00:00:00.000;

    doi:10.1038/sj.bjc.6603843

  • Törnqvist, M

    L Hagmar and M Törnqvist

    Inconclusive results from an epidemiological study on dietary acrylamide and cancer

    doi:10.1038/sj.bjc.6601016

  • Tötsch, M

    D C Betticher, S-F Hsu Schmitz, M Tötsch, E Hansen, C Joss, C von Briel, R A Schmid, M Pless, J Habicht, A D Roth, A Spiliopoulos, R Stahel, W Weder, R Stupp, F Egli, M Furrer, H Honegger, M Wernli, T Cerny and H-B Ris

    Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

    advance online publication, 2006-04-04 00:00:00.000;

    doi:10.1038/sj.bjc.6603075

  • Taal, B G

    B G Taal, H van Tinteren and L van t Veer

    Adjuvant treatment in colorectal cancer

    doi:10.1038/sj.bjc.6600280

  • G J J Van Doornum, C M Korse, J C G M Buning-Kager, J M G Bonfrer, S Horenblas, B G Taal and J Dillner

    Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites

    doi:10.1038/sj.bjc.6600870

  • B G Taal, H Van Tinteren and F A N Zoetmulder

    Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

    doi:10.1054/bjoc.2001.2117

  • Taamma, A

    L Zelek, A Yovine, E Brain, F Turpin, A Taamma, M Riofrio, M Spielmann, J Jimeno and J L Misset

    A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

    doi:10.1038/sj.bjc.6603142